Aygoren-Pursun E, Zanichelli A, Cohn DM, Cancian M, et al. An investigational oral plasma kallikrein inhibitor for on-demand treatment of hereditary angioedema: a two-part, randomised, double-blind, placebo-controlled, crossover phase 2 trial. Lancet 2023;401:458-469.
PMID: 36774155